Terms: = Breast cancer AND TAF15, hTAFII68, 8148, ENSG00000172660, TAF2N, RBP56, Npl3, Q92804
9 results:
1. CircDNAJC11 interacts with taf15 to promote breast cancer progression via enhancing MAPK6 expression and activating the MAPK signaling pathway.
Wang B; Chen H; Deng Y; Chen H; Xing L; Guo Y; Wang M; Chen J
J Transl Med; 2023 Mar; 21(1):186. PubMed ID: 36895010
[TBL] [Abstract] [Full Text] [Related]
2. Long non-coding RNA SNHG4 enhances RNF14 mRNA stability to promote the progression of colorectal cancer by recruiting taf15 protein.
Lv L; Huang B; Yi L; Zhang L
Apoptosis; 2023 Apr; 28(3-4):414-431. PubMed ID: 36482019
[TBL] [Abstract] [Full Text] [Related]
3. Nontherapeutic Risk Factors of Different Grouped Stage IIIC breast cancer Patients' Mortality: A Study of the US Surveillance, Epidemiology, and End Results Database.
Qiu Y; Chen H; Dai Y; Bao B; Tian L; Chen Y
Breast J; 2022; 2022():6705052. PubMed ID: 36111212
[TBL] [Abstract] [Full Text] [Related]
4. STAT1 mediated long non-coding RNA LINC00504 influences radio-sensitivity of breast cancer via binding to taf15 and stabilizing CPEB2 expression.
Feng J; Li Y; Zhu L; Zhao Q; Li D; Li Y; Wu T
Cancer Biol Ther; 2021 Dec; 22(10-12):630-639. PubMed ID: 34908514
[TBL] [Abstract] [Full Text] [Related]
5. Phase transition of fibrillarin LC domain regulates localization and protein interaction of fibrillarin.
Kim E; Kwon I
Biochem J; 2021 Feb; 478(4):799-810. PubMed ID: 33522570
[TBL] [Abstract] [Full Text] [Related]
6. Reflex Estrogen Receptor (ER) and Progesterone Receptor (PR) Analysis of Ductal Carcinoma In Situ (DCIS) in breast Needle Core Biopsy Specimens: An Unnecessary Exercise That Costs the United States $35 Million/y.
VandenBussche CJ; Cimino-Mathews A; Park BH; Emens LA; Tsangaris TN; Argani P
Am J Surg Pathol; 2016 Aug; 40(8):1090-9. PubMed ID: 27299796
[TBL] [Abstract] [Full Text] [Related]
7. Assessment of tumor characteristics and factors affecting survival in patients with primary metastatic breast carcinoma: a Multicenter Study of the Anatolian Society of Medical Oncology.
Uyeturk U; Oksuzoglu B; Akman T; Turker I; Sener N; Tastekin D; Bal O; Berk V; Arslan UY; Urakci Z; Bilir C; Yilmaz U; Yazilitas D; Ulas A; Sonmez OU; Budakoglu B; Cihan S; Uysal M
Med Oncol; 2014 Apr; 31(4):929. PubMed ID: 24659267
[TBL] [Abstract] [Full Text] [Related]
8. Trastuzumab in adjuvant breast cancer therapy. A model based cost-effectiveness analysis.
Norum J; Olsen JA; Wist EA; Lønning PE
Acta Oncol; 2007; 46(2):153-64. PubMed ID: 17453363
[TBL] [Abstract] [Full Text] [Related]
9. [Cytopathological scrape examination of superficial lesions of skin and mucosal membrane--a cytological and histological comparative study of 148 cases].
Yu XM; Wang WD; Zhang CH; Huang SF
Zhonghua Bing Li Xue Za Zhi; 2005 Oct; 34(10):637-40. PubMed ID: 16536275
[TBL] [Abstract] [Full Text] [Related]
